Caris is a molecular science company that creates and delivers solutions to transform healthcare and improve cancer patient outcomes.
Caris Molecular Intelligence revolutionizes precision medicine to provide physicians and patients with information about their health. They develop Caris Molecular Intelligence Services which does panomic molecular profiling for oncology.Caris Life Sciences was founded with a very simple but powerful purpose – to help improve the lives of as many people as possible. Through tireless efforts, breakthrough molecular science, and a passionate commitment to quality, they remain steadfastly focused on the most important part of their work – the patient.It was founded in 1996 and is based in Irving, Texas.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 11, 2021 | Private Equity(PE) | $830M | 18 | Sixth Street Partners | — | Detail |
Oct 27, 2020 | Debt Financing | $75M | 1 | Sixth Street Partners | — | Detail |
Oct 27, 2020 | Private Equity(PE) | $235M | 9 | Coatue Highland Capital Management, LP. | — | Detail |
Oct 1, 2018 | Debt Financing | $150M | 2 | Sixth Street Partners | — | Detail |